Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The role of baseline HIV-1 RNA, drug resistance, and regimen type as determinants of response to first-line antiretroviral therapy.

Journal of medical virology - 1 Oct 2014

Di Biagio Antonio, Rusconi Stefano, Marzocchetti Angela, Signori Alessio, Schiavetti Irene, Bruzzone Bianca, Monno Laura, Punzi Grazia, Colao Maria Grazia, Penco Giovanni, Zazzi Maurizio, De Luca Andrea

Abstract excerpt

The factors influencing virological response to first-line combined antiretroviral therapy (cART) in an Italian cohort of HIV-1-infected patients were examined. Eligible patients were those enrolled in a national prospective observational cohort (Antiretroviral Resistance Cohort Analysis), starting first-line cART between 2001 and 2011 and who had at least one follow-up of HIV-1 RNA. The primary endpoint was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Retroviral Agents
Share to Antiretroviral Therapy, Highly Active

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to CD4 Lymphocyte Count

Share to Drug Resistance, Viral

Share to HIV Infections

Share to Longitudinal Studies

Share to Viral Load

Source

Identifiers

PMID: 25042976
DOI: 10.1002/jmv.24017

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The role of baseline HIV-1 RNA, drug resistance, and regimen type as determinants of response to first-line antiretroviral therapy.PMID 25042976Read ↗

Evolution and predictors of HIV type-1 drug resistance in patients failing combination antiretroviral therapy in Italy.Semantic proximity Read ↗

Trends and correlates of HIV-1 resistance among subjects failing an antiretroviral treatment over the 2003-2012 decade in Italy.Semantic proximity Read ↗

HIV MDR is still a relevant issue despite its dramatic drop over the years.Semantic proximity Read ↗

First line treatment response in patients with transmitted HIV drug resistance and well defined time point of HIV infection: updated results from the German HIV-1 seroconverter study.Semantic proximity Read ↗

Impact of transmitted HIV-1 drug resistance on the efficacy of first-line antiretroviral therapy with two nucleos(t)ide reverse transcriptase inhibitors plus an integrase inhibitor or a protease inhibitor.Semantic proximity Read ↗

The effect of HIV-1 resistance mutations after first-line virological failure on the possibility to sequence antiretroviral drugs in second-line regimens.Semantic proximity Read ↗

Cohort profile: PRESTIGIO, an Italian prospective registry-based cohort of people with HIV-1 resistant to reverse transcriptase, protease and integrase inhibitorsSemantic proximity Read ↗

Marked decrease in acquired resistance to antiretrovirals in latest years in Italy.Semantic proximity Read ↗

Prevalence of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy: evolution over 12 years and predictors.Semantic proximity Read ↗

Baseline HIV-1 resistance, virological outcomes, and emergent resistance in the SECOND-LINE trial: an exploratory analysisSemantic proximity Read ↗

Evolution of HIV-1 transmitted drug resistance in Italy in the 2007-2014 period: A weighted analysis.Semantic proximity Read ↗

Resistance and virological response analyses in a three initial treatment strategy trial: a substudy of the INITIO trial.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.